vs
MACOM Technology Solutions Holdings, Inc.（MTSI）与Tarsus Pharmaceuticals, Inc.（TARS）财务数据对比。点击上方公司名可切换其他公司
MACOM Technology Solutions Holdings, Inc.的季度营收约是Tarsus Pharmaceuticals, Inc.的1.9倍（$289.0M vs $151.7M），MACOM Technology Solutions Holdings, Inc.净利率更高（16.0% vs -5.5%，领先21.6%），Tarsus Pharmaceuticals, Inc.同比增速更快（128.4% vs 22.5%），过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高（134.4% vs 23.2%）
MACOM是美国知名的射频、微波及毫米波半导体器件与组件研发生产商，总部位于马萨诸塞州洛厄尔，2005年曾是当地规模最大的私营雇主。公司已通过ISO9001国际质量体系认证及ISO14001环境管理体系认证，在北美、欧洲、亚洲及澳大利亚均设有设计中心与销售办事处。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司，专注于眼科、皮肤科等专科领域创新疗法的研发和商业化，主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症，核心市场为美国。
MTSI vs TARS — 直观对比
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $289.0M | $151.7M |
| 净利润 | $46.3M | $-8.4M |
| 毛利率 | 56.9% | — |
| 营业利润率 | 17.6% | -5.3% |
| 净利率 | 16.0% | -5.5% |
| 营收同比 | 22.5% | 128.4% |
| 净利润同比 | 46.3% | 63.8% |
| 每股收益（稀释后） | $0.60 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q2 26 | $289.0M | — | ||
| Q1 26 | $271.6M | — | ||
| Q4 25 | $261.2M | $151.7M | ||
| Q3 25 | $252.1M | $118.7M | ||
| Q2 25 | $235.9M | $102.7M | ||
| Q1 25 | $218.1M | $78.3M | ||
| Q4 24 | — | $66.4M | ||
| Q3 24 | $200.7M | $48.1M |
| Q2 26 | $46.3M | — | ||
| Q1 26 | $48.8M | — | ||
| Q4 25 | $45.1M | $-8.4M | ||
| Q3 25 | $36.5M | $-12.6M | ||
| Q2 25 | $31.7M | $-20.3M | ||
| Q1 25 | $-167.5M | $-25.1M | ||
| Q4 24 | — | $-23.1M | ||
| Q3 24 | $29.4M | $-23.4M |
| Q2 26 | 56.9% | — | ||
| Q1 26 | 55.9% | — | ||
| Q4 25 | 54.5% | — | ||
| Q3 25 | 55.3% | — | ||
| Q2 25 | 55.2% | — | ||
| Q1 25 | 53.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.7% | — |
| Q2 26 | 17.6% | — | ||
| Q1 26 | 15.9% | — | ||
| Q4 25 | 15.2% | -5.3% | ||
| Q3 25 | 14.9% | -12.2% | ||
| Q2 25 | 14.8% | -21.6% | ||
| Q1 25 | 8.0% | -33.5% | ||
| Q4 24 | — | -36.8% | ||
| Q3 24 | 13.7% | -52.3% |
| Q2 26 | 16.0% | — | ||
| Q1 26 | 18.0% | — | ||
| Q4 25 | 17.3% | -5.5% | ||
| Q3 25 | 14.5% | -10.6% | ||
| Q2 25 | 13.4% | -19.8% | ||
| Q1 25 | -76.8% | -32.1% | ||
| Q4 24 | — | -34.8% | ||
| Q3 24 | 14.7% | -48.7% |
| Q2 26 | $0.60 | — | ||
| Q1 26 | $0.64 | — | ||
| Q4 25 | $0.67 | $-0.17 | ||
| Q3 25 | $0.48 | $-0.30 | ||
| Q2 25 | $0.42 | $-0.48 | ||
| Q1 25 | $-2.30 | $-0.64 | ||
| Q4 24 | — | $-0.57 | ||
| Q3 24 | $0.40 | $-0.61 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $664.9M | $417.3M |
| 总债务越低越好 | $0 | $72.4M |
| 股东权益账面价值 | — | $343.4M |
| 总资产 | $2.0B | $562.2M |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势，按日历期对齐
| Q2 26 | $664.9M | — | ||
| Q1 26 | $768.5M | — | ||
| Q4 25 | $786.0M | $417.3M | ||
| Q3 25 | $735.2M | $401.8M | ||
| Q2 25 | $681.5M | $381.1M | ||
| Q1 25 | $656.5M | $407.9M | ||
| Q4 24 | — | $291.4M | ||
| Q3 24 | $581.9M | $317.0M |
| Q2 26 | $0 | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | $72.4M | ||
| Q3 25 | — | $72.3M | ||
| Q2 25 | — | $72.1M | ||
| Q1 25 | — | $72.0M | ||
| Q4 24 | — | $71.8M | ||
| Q3 24 | — | $71.7M |
| Q2 26 | — | — | ||
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.3B | $343.4M | ||
| Q3 25 | $1.3B | $335.1M | ||
| Q2 25 | $1.2B | $332.6M | ||
| Q1 25 | $1.2B | $342.5M | ||
| Q4 24 | — | $224.5M | ||
| Q3 24 | $1.1B | $237.5M |
| Q2 26 | $2.0B | — | ||
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.1B | $562.2M | ||
| Q3 25 | $2.0B | $534.6M | ||
| Q2 25 | $1.9B | $495.0M | ||
| Q1 25 | $1.8B | $500.8M | ||
| Q4 24 | — | $377.0M | ||
| Q3 24 | $1.8B | $376.3M |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.30× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $121.6M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | — | $13.0M |
| 自由现金流率自由现金流/营收 | — | 8.6% |
| 资本支出强度资本支出/营收 | — | 4.2% |
| 现金转化率经营现金流/净利润 | 2.62× | — |
| 过去12个月自由现金流最近4个季度 | — | $-22.3M |
8季度趋势，按日历期对齐
| Q2 26 | $121.6M | — | ||
| Q1 26 | $42.9M | — | ||
| Q4 25 | $69.6M | $19.3M | ||
| Q3 25 | $60.4M | $18.3M | ||
| Q2 25 | $38.7M | $-29.4M | ||
| Q1 25 | $66.7M | $-20.7M | ||
| Q4 24 | — | $-22.2M | ||
| Q3 24 | $62.3M | $-8.7M |
| Q2 26 | — | — | ||
| Q1 26 | $30.0M | — | ||
| Q4 25 | $49.4M | $13.0M | ||
| Q3 25 | $51.6M | $16.3M | ||
| Q2 25 | $30.5M | $-30.4M | ||
| Q1 25 | $61.3M | $-21.2M | ||
| Q4 24 | — | $-22.3M | ||
| Q3 24 | $57.1M | $-8.9M |
| Q2 26 | — | — | ||
| Q1 26 | 11.0% | — | ||
| Q4 25 | 18.9% | 8.6% | ||
| Q3 25 | 20.5% | 13.8% | ||
| Q2 25 | 12.9% | -29.6% | ||
| Q1 25 | 28.1% | -27.1% | ||
| Q4 24 | — | -33.5% | ||
| Q3 24 | 28.5% | -18.6% |
| Q2 26 | — | — | ||
| Q1 26 | 4.8% | — | ||
| Q4 25 | 7.7% | 4.2% | ||
| Q3 25 | 3.5% | 1.6% | ||
| Q2 25 | 3.5% | 1.0% | ||
| Q1 25 | 2.4% | 0.8% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | 2.6% | 0.6% |
| Q2 26 | 2.62× | — | ||
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.54× | — | ||
| Q3 25 | 1.65× | — | ||
| Q2 25 | 1.22× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.12× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
